These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2805458)

  • 1. The role of soluble immune response suppressor lymphokine in the prediction of steroid responsiveness in idiopathic nephrotic syndrome.
    Cheng IK; Jones BM; Chan PC; Chan MK
    Clin Nephrol; 1989 Oct; 32(4):168-72. PubMed ID: 2805458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid-sensitive mechanism of soluble immune response suppressor production in steroid-responsive nephrotic syndrome.
    Schnaper HW; Aune TM
    J Clin Invest; 1987 Jan; 79(1):257-64. PubMed ID: 3793925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the lymphokine soluble immune response suppressor in urine of nephrotic children.
    Schnaper HW; Aune TM
    J Clin Invest; 1985 Jul; 76(1):341-9. PubMed ID: 4019784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications of blood soluble and cell surface tumor necrosis factor receptors in childhood nephrotic syndrome.
    Tain YL; Liu CA; Yang KD
    Pediatr Nephrol; 2002 Nov; 17(11):926-32. PubMed ID: 12432436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for histamine type II (H-2) receptor binding in production of the lymphokine, soluble immune response suppressor (SIRS).
    Schnaper HW; Aune TM; Roby RK
    J Immunol; 1987 Aug; 139(4):1185-90. PubMed ID: 2440946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum neopterin levels in children with primary nephrotic syndrome.
    Bakr A; Rageh I; el-Azouny M; Deyab S; Lotfy H
    Acta Paediatr; 2006 Jul; 95(7):854-6. PubMed ID: 16801184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular permeability activity: prevalence and prognostic value in pediatric patients with idiopathic nephrotic syndrome.
    Trachtman H; Greenbaum LA; McCarthy ET; Sharma M; Gauthier BG; Frank R; Warady B; Savin VJ
    Am J Kidney Dis; 2004 Oct; 44(4):604-10. PubMed ID: 15384010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pefloxacin in steroid dependent and resistant idiopathic nephrotic syndrome.
    Sharma RK; Sahu KM; Gulati S; Gupta A
    J Nephrol; 2000; 13(4):271-4. PubMed ID: 10946806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children.
    Hamed RM
    J Nephrol; 1997; 10(5):266-70. PubMed ID: 9364319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A regulatory system for soluble immune response suppressor production in steroid-responsive nephrotic syndrome.
    Schnaper HW
    Kidney Int; 1990 Jul; 38(1):151-9. PubMed ID: 1696648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of enalapril in the treatment of steroid resistant idiopathic nephrotic syndrome.
    Prasher PK; Varma PP; Baliga KV
    J Assoc Physicians India; 1999 Feb; 47(2):180-2. PubMed ID: 10999084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome.
    Daniel V; Trautmann Y; Konrad M; Nayir A; Schärer K
    Clin Nephrol; 1997 May; 47(5):289-97. PubMed ID: 9181275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nephrotic syndrome in childhood].
    Reusz G; Szabó A; Fekete A
    Orv Hetil; 2006 Nov; 147(47):2251-60. PubMed ID: 17380687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine in the therapy of steroid-resistant idiopathic nephrotic syndrome.
    Niaudet P; Fuchshuber A; Gagnadoux MF; Habib R; Broyer M
    Kidney Int Suppl; 1997 Mar; 58():S85-90. PubMed ID: 9067953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin in the treatment of steroid-responsive and steroid-resistant nephrotic syndrome in adults.
    Maher ER; Sweny P; Chappel M; Varghese Z; Moorhead JF
    Nephrol Dial Transplant; 1988; 3(6):728-32. PubMed ID: 3147413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of steroid resistant nephrotic syndrome in children living in the kingdom of Saudi Arabia: a single center study.
    Kari JA; Halawani M; Mokhtar G; Jalalah SM; Anshasi W
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):854-7. PubMed ID: 19736491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-oxidant status in relation to lipoproteins, leptin and pro-inflammatory cytokines in children with steroid-sensitive nephrotic syndrome.
    Ece A; Atamer Y; Gürkan F; Bilici M; Koçyiğit Y
    Nephrology (Carlton); 2004 Dec; 9(6):366-73. PubMed ID: 15663638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of idiopathic nephrotic syndrome with cyclosporine A.
    Meyrier A
    J Nephrol; 1997; 10(1):14-24. PubMed ID: 9241620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-18 is correlated with type-2 immune response in children with steroid sensitive nephrotic syndrome.
    Printza N; Papachristou F; Tzimouli V; Taparkou A; Kanakoudi-Tsakalidou F
    Cytokine; 2008 Nov; 44(2):262-8. PubMed ID: 18819819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.